Company / Current Assets
ANI Pharmaceuticals, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$753.1M
FY2025
5-year range
$321.8M / $753.1M
FY2021-FY2025
Trend
+42.5%
vs FY2024
Sector context
#75 of 213
Health Care
What the data says
At $753M, ANI Pharmaceuticals, Inc.'s current assets ranks #75 of 213 in the Health Care sector. Current Assets has increased for 5 consecutive years, from $170M in FY2020 to $753M in FY2025.
Based on SEC 10-K filings.
$753M in FY2025 with a 5-year CAGR of +34.6%.
Improved from $520M to $753M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +29.8%
- 5-Year CAGR
- +34.6%
- 10-Year CAGR
- -
Sector benchmark
#75 of 213 in Health CareTop 35% of 213This company $753.1M Sector average $2.5B
▼
-70.1% below sector average
Key checks
Key Insights
- ANI Pharmaceuticals, Inc.'s current assets has grown for 5 consecutive years.
- 5-year CAGR of +34.6%, indicating consistent growth.
- In FY2025, current assets increased 42.5% year-over-year.
- Ranks #75 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $753.1M | +42.5% |
| FY2024 | $528.5M | +1.7% |
| FY2023 | $519.8M | +51.0% |
| FY2022 | $344.3M | +7.0% |
| FY2021 | $321.8M | +88.9% |
| FY2020 | $170.3M | -9.3% |
| FY2019 | $187.7M | +22.8% |
| FY2018 | $152.9M | +16.2% |
| FY2017 | $131.6M | +27.8% |
| FY2016 | $103.0M | -46.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026